Skip to main content
Erschienen in: Journal of Nanoparticle Research 8/2012

01.08.2012 | Perspectives

Responsible nanotechnology development

verfasst von: Gianluigi Forloni

Erschienen in: Journal of Nanoparticle Research | Ausgabe 8/2012

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Nanotechnologies have an increasing relevance in our life, numerous products already on the market are associated with this new technology. Although the chemical constituents of nanomaterials are often well known, the properties at the nano level are completely different from the bulk materials. Independently from the specific application the knowledge in this field involves different type of scientific competence. The accountability of the nanomaterial research imply the parallel development of innovative methodological approaches to assess and manage the risks associated to the exposure for humans and environmental to the nanomaterials for their entire life-cycle: production, application, use and waste discharge. The vast numbers of applications and the enormous amount of variables influencing the characteristics of the nanomaterials make particularly difficult the elaboration of appropriate nanotoxicological protocols. According to the official declarations exist an awareness of the public institutions in charge of the regulatory system, about the environmental, health and safety implications of nanotechnology, but the scientific information is insufficient to support appropriate mandatory rules. Public research programmers must play an important role in providing greater incentives and encouragement for nanotechnologies that support sustainable development to avoid endangering humanity’s well being in the long-term. The existing imbalance in funds allocated to nanotech research needs to be corrected so that impact assessment and minimization and not only application come high in the agenda. Research funding should consider as a priority the elimination of knowledge gaps instead of promoting technological application only. With the creation of a public register collecting nanomaterials and new applications it is possible, starting from the information available, initiate a sustainable route, allowing the gradual development of a rational and informed approach to the nanotoxicology. The establishment of an effective strategy cannot ignore the distinction between different nanoparticles on their use and the type of exposure to which we are subjected. Categorization is essential to orchestrate toxicological rules realistic and effective. The responsible development of nanotechnology means a common effort, by scientists, producers, stakeholders, and public institutions to develop appropriate programs to systematically approach the complex issue of the nanotoxicology.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Literatur
Zurück zum Zitat Bosi S, Da Ros T, Spalluto G, Prato M (2003) Fullerene derivatives: an attractive tool for biological applications. Eur J Med Chem 38:913–923CrossRef Bosi S, Da Ros T, Spalluto G, Prato M (2003) Fullerene derivatives: an attractive tool for biological applications. Eur J Med Chem 38:913–923CrossRef
Zurück zum Zitat Bottini M, Rosato N, Gloria F, Adanti S, Corradino N, Bergamaschi A, Magrini A (2011) Public optimism towards nanomedicine. Int J Nanomed 6:3473–3485CrossRef Bottini M, Rosato N, Gloria F, Adanti S, Corradino N, Bergamaschi A, Magrini A (2011) Public optimism towards nanomedicine. Int J Nanomed 6:3473–3485CrossRef
Zurück zum Zitat Burgess P, Hutt PB, Farokhzad OC, Langer R, Minick S, Zale S (2010) On firm ground: IP protection of therapeutic nanoparticles. Nat Biotechnol 28:1267–1270CrossRef Burgess P, Hutt PB, Farokhzad OC, Langer R, Minick S, Zale S (2010) On firm ground: IP protection of therapeutic nanoparticles. Nat Biotechnol 28:1267–1270CrossRef
Zurück zum Zitat Cattaneo AG, Gornati R, Sabbioni E, Chiriva-Internati M, Cobos E, Jenkins MR, Bernardini G (2010) Nanotechnology and human health: risks and benefits. J Appl Toxicol 30:730–744. doi:10.1002/jat.1609 CrossRef Cattaneo AG, Gornati R, Sabbioni E, Chiriva-Internati M, Cobos E, Jenkins MR, Bernardini G (2010) Nanotechnology and human health: risks and benefits. J Appl Toxicol 30:730–744. doi:10.​1002/​jat.​1609 CrossRef
Zurück zum Zitat Choi J-Y, Ramachandran G, Kandlikar M (2009) The impact of toxicity testing costs on nanomaterial regulation. Environ Sci Technol 43:3030–3034CrossRef Choi J-Y, Ramachandran G, Kandlikar M (2009) The impact of toxicity testing costs on nanomaterial regulation. Environ Sci Technol 43:3030–3034CrossRef
Zurück zum Zitat Cormick C (2012) The complexity of public engagement. Nat Nanotechnol 7:77–78CrossRef Cormick C (2012) The complexity of public engagement. Nat Nanotechnol 7:77–78CrossRef
Zurück zum Zitat Durdagi S, Mavromoustakos T, Papadopoulos MG (2008) 3D QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies of fullerene-based HIV-1 PR inhibitors. Bioorg Med Chem Lett 18:6283–6289CrossRef Durdagi S, Mavromoustakos T, Papadopoulos MG (2008) 3D QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies of fullerene-based HIV-1 PR inhibitors. Bioorg Med Chem Lett 18:6283–6289CrossRef
Zurück zum Zitat Durdagi S, Supuran CT, Strom TA, Doostdar N, Kumar MK, Barron AR, Mavromoustakos T, Papadopoulos MG (2009) In silico drug screening approach for the design of magic bullets: a successful example with anti-HIV fullerene derivatized amino acids. J Chem Inf Model 49:1139–1143CrossRef Durdagi S, Supuran CT, Strom TA, Doostdar N, Kumar MK, Barron AR, Mavromoustakos T, Papadopoulos MG (2009) In silico drug screening approach for the design of magic bullets: a successful example with anti-HIV fullerene derivatized amino acids. J Chem Inf Model 49:1139–1143CrossRef
Zurück zum Zitat Dusinska M, Dusinska M, Fjellsbø L, Magdolenova Z, Rinna A, Runden Pran E, Bartonova A, Heimstad E, Harju M, Tran L, Ross B, Juillerat L, Halamoda Kenzaui B, Marano F, Boland S, Guadaginini R, Saunders M, Cartwright L, Carreira S, Whelan M, Kelin Ch, Worth A, Palosaari T, Burello E, Housiadas C, Pilou M, Volkovova K, Tulinska J, Kazimirova A, Barancokova M, Sebekova K, Hurbankova M, Kovacikova Z, Knudsen L, Poulsen M, Mose T, Vilà M, Gombau L, Fernandez B, Castell J, Marcomini A, Pojana G, Bilanicova D, Vallotto D (2009) Testing strategies for the safety of nanoparticles used in medical applications. Nanomedicine (Lond) 4:605–607CrossRef Dusinska M, Dusinska M, Fjellsbø L, Magdolenova Z, Rinna A, Runden Pran E, Bartonova A, Heimstad E, Harju M, Tran L, Ross B, Juillerat L, Halamoda Kenzaui B, Marano F, Boland S, Guadaginini R, Saunders M, Cartwright L, Carreira S, Whelan M, Kelin Ch, Worth A, Palosaari T, Burello E, Housiadas C, Pilou M, Volkovova K, Tulinska J, Kazimirova A, Barancokova M, Sebekova K, Hurbankova M, Kovacikova Z, Knudsen L, Poulsen M, Mose T, Vilà M, Gombau L, Fernandez B, Castell J, Marcomini A, Pojana G, Bilanicova D, Vallotto D (2009) Testing strategies for the safety of nanoparticles used in medical applications. Nanomedicine (Lond) 4:605–607CrossRef
Zurück zum Zitat Fadeel B, Garcia-Bennett AE (2010) Better safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Adv Drug Deliv Rev 62:362–374CrossRef Fadeel B, Garcia-Bennett AE (2010) Better safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Adv Drug Deliv Rev 62:362–374CrossRef
Zurück zum Zitat Fiorino DJ (2010) Voluntary initiative, regulation, and nanotechnology oversight: charting a path. Project in Emerging Nanotechnology PEN 19 Fiorino DJ (2010) Voluntary initiative, regulation, and nanotechnology oversight: charting a path. Project in Emerging Nanotechnology PEN 19
Zurück zum Zitat Foss Hansen S, Larsen BH, Olsen SI, Baun A (2007) Categorization framework to aid hazard identification of nanomaterials. Nanotoxicology 1:243–250CrossRef Foss Hansen S, Larsen BH, Olsen SI, Baun A (2007) Categorization framework to aid hazard identification of nanomaterials. Nanotoxicology 1:243–250CrossRef
Zurück zum Zitat Foss Hansen S, Maynard A, Baun A, Tickner JA (2008) Late lessons from early warnings for nanotechnology. Nat Nanotechnol 3:444–447CrossRef Foss Hansen S, Maynard A, Baun A, Tickner JA (2008) Late lessons from early warnings for nanotechnology. Nat Nanotechnol 3:444–447CrossRef
Zurück zum Zitat Garcia-Bennett A, Nees M, Fadeel B (2011) In search of the Holy Grail: folate-targeted nanoparticles for cancer therapy. Biochem Pharmacol 81:976–984CrossRef Garcia-Bennett A, Nees M, Fadeel B (2011) In search of the Holy Grail: folate-targeted nanoparticles for cancer therapy. Biochem Pharmacol 81:976–984CrossRef
Zurück zum Zitat Gee D (2009) Late lessons from early warnings: towards realism and precaution with EMF? Pathophysiology 16:217–231 Gee D (2009) Late lessons from early warnings: towards realism and precaution with EMF? Pathophysiology 16:217–231
Zurück zum Zitat Kahan DM, Braman D, Slovic P, Gastil J, Cohen G (2009) Cultural cognition of the risks and benefits of nanotechnology. Nat Nanotechnol 4:87–90CrossRef Kahan DM, Braman D, Slovic P, Gastil J, Cohen G (2009) Cultural cognition of the risks and benefits of nanotechnology. Nat Nanotechnol 4:87–90CrossRef
Zurück zum Zitat Kane AB, Hurt RH (2008) Nanotoxicology: the asbestos analogy revisited. Nat Nanotechnol 3:378–379CrossRef Kane AB, Hurt RH (2008) Nanotoxicology: the asbestos analogy revisited. Nat Nanotechnol 3:378–379CrossRef
Zurück zum Zitat Linkov I, Steevens J, Adlakha-Hutcheon G, Bennett E, Chappell M, Colvin V, Davis JM, Davis T, Elder A, Foss Hansen S, Hakkinen PB, Hussain SM, Karkan D, Korenstein R, Lynch I, Metcalfe C, Ramadan AB, Satterstrom FK (2009) Emerging methods and tools for environmental risk assessment, decision-making, and policy for nanomaterials: summary of NATO Advanced Research Workshop. J Nanopart Res 1:513–527CrossRef Linkov I, Steevens J, Adlakha-Hutcheon G, Bennett E, Chappell M, Colvin V, Davis JM, Davis T, Elder A, Foss Hansen S, Hakkinen PB, Hussain SM, Karkan D, Korenstein R, Lynch I, Metcalfe C, Ramadan AB, Satterstrom FK (2009) Emerging methods and tools for environmental risk assessment, decision-making, and policy for nanomaterials: summary of NATO Advanced Research Workshop. J Nanopart Res 1:513–527CrossRef
Zurück zum Zitat Liu W, Wu Y, Wang C, Li HC, Wang T, Liao CY, Cui L, Zhou QF, Yan B, Jiang GB (2010) Impact of silver nanoparticles on human cells: effect of particle size. Nanotoxicology 4:319–330 Liu W, Wu Y, Wang C, Li HC, Wang T, Liao CY, Cui L, Zhou QF, Yan B, Jiang GB (2010) Impact of silver nanoparticles on human cells: effect of particle size. Nanotoxicology 4:319–330
Zurück zum Zitat Lorenz C, Von Goetz N, Scheringer M, Wormuth M, Hungerbühler K (2011) Potential exposure of German consumers to engineered nanoparticles in cosmetics and personal care products. Nanotoxicology 5:12–29CrossRef Lorenz C, Von Goetz N, Scheringer M, Wormuth M, Hungerbühler K (2011) Potential exposure of German consumers to engineered nanoparticles in cosmetics and personal care products. Nanotoxicology 5:12–29CrossRef
Zurück zum Zitat Ma Y (2009) In vitro models for nanotoxicity testing. In: Sahu SC, Casciano DA (eds) Nanotoxicity. Wiley, New York, pp 349–377CrossRef Ma Y (2009) In vitro models for nanotoxicity testing. In: Sahu SC, Casciano DA (eds) Nanotoxicity. Wiley, New York, pp 349–377CrossRef
Zurück zum Zitat Maurer-Jones MA, Lin Y-S, Haynes CL (2010) Functional assessment of metal oxide nanoparticle toxicity in immune cells. ACS Nano 4:3363–3373CrossRef Maurer-Jones MA, Lin Y-S, Haynes CL (2010) Functional assessment of metal oxide nanoparticle toxicity in immune cells. ACS Nano 4:3363–3373CrossRef
Zurück zum Zitat Maynard AD, Aitken RJ, Butz T, Colvin V, Donaldson K, Oberdörster G, Philbert MA, Ryan J, Seaton A, Stone V, Tinkle SS, Tran L, Walker NJ, Warheit DB (2006) Safe handling of nanotechnology. Nature 444:267–269CrossRef Maynard AD, Aitken RJ, Butz T, Colvin V, Donaldson K, Oberdörster G, Philbert MA, Ryan J, Seaton A, Stone V, Tinkle SS, Tran L, Walker NJ, Warheit DB (2006) Safe handling of nanotechnology. Nature 444:267–269CrossRef
Zurück zum Zitat McCall M (2011) Nanoparticles in the real world. Nat Nanotechnol 6:613–614CrossRef McCall M (2011) Nanoparticles in the real world. Nat Nanotechnol 6:613–614CrossRef
Zurück zum Zitat Menjoge AR, Kannan RM, Tomalia DA (2010) Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. Drug Discov Today 15:171–185CrossRef Menjoge AR, Kannan RM, Tomalia DA (2010) Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. Drug Discov Today 15:171–185CrossRef
Zurück zum Zitat Moore MN (2006) Do nanoparticles present ecotoxicological risks for the health of the aquatic environment? Environ Int 32:967–976CrossRef Moore MN (2006) Do nanoparticles present ecotoxicological risks for the health of the aquatic environment? Environ Int 32:967–976CrossRef
Zurück zum Zitat Morimoto Y, Hirohashi M, Ogami A, Oyabu T, Myojo T, Todoroki M, Yamamoto M, Hashiba M, Mizuguchi Y, Lee BW, Kuroda E, Shimada M, Wang WN, Yamamoto K, Fujita K, Endoh S, Uchida K, Kobayashi N, Mizuno K, Inada M, Tao H, Nakazato T, Nakanishi J, Tanaka I (2011) Pulmonary toxicity of well-dispersed multi-wall carbon nanotubes following inhalation and intratracheal instillation. Nanotoxicology (in press) Morimoto Y, Hirohashi M, Ogami A, Oyabu T, Myojo T, Todoroki M, Yamamoto M, Hashiba M, Mizuguchi Y, Lee BW, Kuroda E, Shimada M, Wang WN, Yamamoto K, Fujita K, Endoh S, Uchida K, Kobayashi N, Mizuno K, Inada M, Tao H, Nakazato T, Nakanishi J, Tanaka I (2011) Pulmonary toxicity of well-dispersed multi-wall carbon nanotubes following inhalation and intratracheal instillation. Nanotoxicology (in press)
Zurück zum Zitat Morris J, Willis J, De Martinis D, Hansen B, Laursen H, Sintes JR, Kearns P, Gonzalez M (2011) Science policy considerations for responsible nanotechnology decisions. Nat Nanotechnol 6:73–77CrossRef Morris J, Willis J, De Martinis D, Hansen B, Laursen H, Sintes JR, Kearns P, Gonzalez M (2011) Science policy considerations for responsible nanotechnology decisions. Nat Nanotechnol 6:73–77CrossRef
Zurück zum Zitat Murphy FA, Poland CA, Duffin R, Al-Jamal KT, Ali-Boucetta H, Nunes A, Byrne F, Prina-Mello A, Volkov Y, Li S, Mather SJ, Bianco A, Prato M, Macnee W, Wallace WA, Kostarelos K, Donaldson K (2011) Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura. Am J Pathol 178:2587–2600CrossRef Murphy FA, Poland CA, Duffin R, Al-Jamal KT, Ali-Boucetta H, Nunes A, Byrne F, Prina-Mello A, Volkov Y, Li S, Mather SJ, Bianco A, Prato M, Macnee W, Wallace WA, Kostarelos K, Donaldson K (2011) Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura. Am J Pathol 178:2587–2600CrossRef
Zurück zum Zitat Nel A, Xia T, Mädler L, Li N (2006) Toxic potential of materials at the nanolevel. Science 311:622–627CrossRef Nel A, Xia T, Mädler L, Li N (2006) Toxic potential of materials at the nanolevel. Science 311:622–627CrossRef
Zurück zum Zitat Nijhara R, Balakrishnan K (2006) Bringing nanomedicines to market: regulatory challenges, opportunities, and uncertainties. Nanomedicine 2:127–136CrossRef Nijhara R, Balakrishnan K (2006) Bringing nanomedicines to market: regulatory challenges, opportunities, and uncertainties. Nanomedicine 2:127–136CrossRef
Zurück zum Zitat Oberdörster G, Oberdörster E, Oberdörster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823CrossRef Oberdörster G, Oberdörster E, Oberdörster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823CrossRef
Zurück zum Zitat Ponce De Castillo AM (2011) Nano governance: how should the EU implement nanomaterial traceability? ETUI Police Brief 2:1–4 Ponce De Castillo AM (2011) Nano governance: how should the EU implement nanomaterial traceability? ETUI Police Brief 2:1–4
Zurück zum Zitat Powers KV, Palazuelos M, Brown SC, Roberts SM (2009) Characterization of nanomaterials for toxicological evaluation. In: Sahu SC, Casciano DA (eds) Nanotoxicity. Wiley, New York, pp 1–29CrossRef Powers KV, Palazuelos M, Brown SC, Roberts SM (2009) Characterization of nanomaterials for toxicological evaluation. In: Sahu SC, Casciano DA (eds) Nanotoxicity. Wiley, New York, pp 1–29CrossRef
Zurück zum Zitat Puzyn T, Rasulev B, Gajewicz A, Hu X, Dasari TP, Michalkova A, Hwang HM, Toropov A, Leszczynska D, Leszczynski J (2011) Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles. Nat Nanotechnol 6:175–178CrossRef Puzyn T, Rasulev B, Gajewicz A, Hu X, Dasari TP, Michalkova A, Hwang HM, Toropov A, Leszczynska D, Leszczynski J (2011) Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles. Nat Nanotechnol 6:175–178CrossRef
Zurück zum Zitat Roco MC (2007) The National Nanotechnology Initiative: past, present and future. In: Roco MC (ed) Handbook of nanoscience, engineering and technology, 2nd edn. Taylor and Francis, London Roco MC (2007) The National Nanotechnology Initiative: past, present and future. In: Roco MC (ed) Handbook of nanoscience, engineering and technology, 2nd edn. Taylor and Francis, London
Zurück zum Zitat Sayes CM, Reed KL, Warheit DB (2011) Nanoparticle toxicology: measurements of pulmonary hazard effects following exposures to nanoparticles. Methods Mol Biol 726:313–324CrossRef Sayes CM, Reed KL, Warheit DB (2011) Nanoparticle toxicology: measurements of pulmonary hazard effects following exposures to nanoparticles. Methods Mol Biol 726:313–324CrossRef
Zurück zum Zitat Schaeublin NM, Braydich-Stolle LK, Schrand AM, Miller JM, Hutchison J, Schlager JJ, Hussain SM (2011) Surface charge of gold nanoparticles mediates mechanism of toxicity. Nanoscale 3:410–420CrossRef Schaeublin NM, Braydich-Stolle LK, Schrand AM, Miller JM, Hutchison J, Schlager JJ, Hussain SM (2011) Surface charge of gold nanoparticles mediates mechanism of toxicity. Nanoscale 3:410–420CrossRef
Zurück zum Zitat SCHENHIR (2007) Opinion on the appropriateness of the risk assessment methodology in accordance with the technical guidance documents for new and existing substances for assessing the risks of nanomaterials, June 2007 SCHENHIR (2007) Opinion on the appropriateness of the risk assessment methodology in accordance with the technical guidance documents for new and existing substances for assessing the risks of nanomaterials, June 2007
Zurück zum Zitat Special Eurobarometer 341/Wave 73.1. TNS Opinion & SocialS (2010) Special Eurobarometer 341/Wave 73.1. TNS Opinion & SocialS (2010)
Zurück zum Zitat Stamm H (2011) Risk factors: nanomaterials should be defined. Nature 476:399CrossRef Stamm H (2011) Risk factors: nanomaterials should be defined. Nature 476:399CrossRef
Zurück zum Zitat Stirling A (2012) Opening up the politics of knowledge and power in bioscience. PLoS Biol 10(1):e1001233CrossRef Stirling A (2012) Opening up the politics of knowledge and power in bioscience. PLoS Biol 10(1):e1001233CrossRef
Zurück zum Zitat Taniguchi N (1975) On the basic concept of ‘nano-technology’. In: Proceedings of international conference on production engineering Tokyo Part II. Japan Society of Precision Engineering Taniguchi N (1975) On the basic concept of ‘nano-technology’. In: Proceedings of international conference on production engineering Tokyo Part II. Japan Society of Precision Engineering
Zurück zum Zitat Tarantola M, Pietuch A, Schneider D, Rother J, Sunnick E, Rosman C, Pierrat S, Sönnichsen C, Wegener J, Janshoff A (2011) Toxicity of gold-nanoparticles: synergistic effects of shape and surface functionalization on micromotility of epithelial cells. Nanotoxicology 5:254–268CrossRef Tarantola M, Pietuch A, Schneider D, Rother J, Sunnick E, Rosman C, Pierrat S, Sönnichsen C, Wegener J, Janshoff A (2011) Toxicity of gold-nanoparticles: synergistic effects of shape and surface functionalization on micromotility of epithelial cells. Nanotoxicology 5:254–268CrossRef
Zurück zum Zitat Tomalia DA (2010) Dendrons/dendrimers: quantized, nano-element like building blocks for soft–soft and soft–hard nano-compound synthesis. Soft Matter 6:456–474CrossRef Tomalia DA (2010) Dendrons/dendrimers: quantized, nano-element like building blocks for soft–soft and soft–hard nano-compound synthesis. Soft Matter 6:456–474CrossRef
Zurück zum Zitat Tourney C (2011) Democratizing nanotech, then and now. Nat Nanotechnol 6:605–606CrossRef Tourney C (2011) Democratizing nanotech, then and now. Nat Nanotechnol 6:605–606CrossRef
Zurück zum Zitat Trout DB, Schulte PA (2010) Medical surveillance, exposure registries, and epidemiologic research for workers exposed to nanomaterials. Toxicology 269:128–135CrossRef Trout DB, Schulte PA (2010) Medical surveillance, exposure registries, and epidemiologic research for workers exposed to nanomaterials. Toxicology 269:128–135CrossRef
Zurück zum Zitat Warheit DB, Webb TR, Colvin VL, Reed KL, Sayes CM (2007) Pulmonary bioassay studies with nanoscale and fine-quartz particles in rats: toxicity is not dependent upon particle size but on surface characteristics. Toxicol Sci 95:270–280CrossRef Warheit DB, Webb TR, Colvin VL, Reed KL, Sayes CM (2007) Pulmonary bioassay studies with nanoscale and fine-quartz particles in rats: toxicity is not dependent upon particle size but on surface characteristics. Toxicol Sci 95:270–280CrossRef
Metadaten
Titel
Responsible nanotechnology development
verfasst von
Gianluigi Forloni
Publikationsdatum
01.08.2012
Verlag
Springer Netherlands
Erschienen in
Journal of Nanoparticle Research / Ausgabe 8/2012
Print ISSN: 1388-0764
Elektronische ISSN: 1572-896X
DOI
https://doi.org/10.1007/s11051-012-1007-1

Weitere Artikel der Ausgabe 8/2012

Journal of Nanoparticle Research 8/2012 Zur Ausgabe

    Marktübersichten

    Die im Laufe eines Jahres in der „adhäsion“ veröffentlichten Marktübersichten helfen Anwendern verschiedenster Branchen, sich einen gezielten Überblick über Lieferantenangebote zu verschaffen.